Afuco™ Anti-TNFSF13B ADCC Therapeutic Antibody (Tabalumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to BAFF. Tabalumab (LY 2127399) is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-216 |
| Pricing | Inquiry |
| Host | Human |
| Target | TNFSF13B |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FuncS, IF, Neut, ELISA, FC, IP |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |